| Q47787912 | A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer |
| Q36868332 | Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited |
| Q36647190 | Differentiated thyroid cancer long-term impact of initial therapy |
| Q45887675 | Drug therapy alternatives in the treatment of thyroid cancer |
| Q34039273 | Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number? |
| Q55603732 | Evaluation of the dosimetry approaches in ablation treatment of thyroid cancer. |
| Q34696392 | Follicular thyroid carcinoma |
| Q37118811 | I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence. |
| Q38598944 | Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer |
| Q35201802 | Low versus high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a meta-analysis of randomized controlled trials. |
| Q33326620 | Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study |
| Q36602187 | Novel Approaches to Thyroid Cancer Treatment and Response Assessment |
| Q41137009 | Radiofrequency ablation for postsurgical thyroid removal of differentiated thyroid carcinoma |
| Q38110763 | Radioiodine therapy for patients with differentiated thyroid cancer after thyroidectomy: direct comparison and network meta-analyses |
| Q34341331 | Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi |
| Q47266547 | Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy |
| Q38571991 | Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology |
| Q46605690 | The early treatment results of well differentiated thyroid cancer and its dependence on chosen factors |
| Q38723039 | The outcome of I-131 ablation therapy for intermediate and high-risk differentiated thyroid cancer using a strict definition of successful ablation |
| Q92617433 | Thyroid Cancer Radiotheragnostics: the case for activity adjusted 131I therapy |